Several studies have demonstrated that initial elevated levels circulating IL-6, plasminogen activator inhibitor-1 (PAI-1), C-reactive protein (CRP) and fibrinogen, are associated with the manifestation of diabetes (Pradhan et al., 2001; Festa et al., 2002; Meigs et al., 2004). This evidence concerns the gene IL6 and diabetes mellitus.